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Reducing the Mortality Gap in People
With Severe Mental Disorders: The
Role of Lifestyle Psychosocial
Interventions
Sarah Barber* and Graham Thornicroft
Centre for Global Mental Health, Institute of Psychiatry, Psychology and Neuroscience, King’s College London, London,
United Kingdom
Thismini-review considers themortality gap in persons with severemental disorder (SMD)
globally. Current estimates of 10–20 years of potential life lost may be too conservative,
both in high (HIC) and low and middle-income countries (LMICs). There is an emerging
consensus that natural causes account for the majority of deaths in persons with
SMD in both resource settings. In HICs, cardiovascular causes predominate, and can
be attributed to individual, health-system and societal level risk factors. Psychosocial
lifestyle interventions target behavior specific risk factors for physical ill-health. There is
good evidence for tailored weight-loss programmes, but mixed evidence for smoking
cessation, substance misuse and risky sexual behavior. In terms of supporting persons
with SMD, nurse-led services and the utilization of peer-support are showing promise.
Future research efforts must focus on effective interventions and health system models
for both high and low resource settings to address this startling health inequality.
Keywords: excessmortality, physical health, severemental disorders, schizophrenia, bipolar disorder, depression,
lifestyle psychosocial interventions, low-and-middle income countries
This mini-review considers the evidence for the mortality disparity between persons with
severe mental disorder (SMD) and the general population worldwide, where SMD is defined as
schizophrenia and other psychotic disorders, bipolar disorder and severe depression. We will
explore the causes of death in high income (HIC) and low and middle-income (LMIC) countries
and review the multi-level risk factor model for mortality in SMD proposed by the World Health
Organization (WHO) (1). Then, focusing on behavioral risk factors, we will discuss the emerging
evidence base for lifestyle psychosocial interventions. Finally, we will consider different models of
professional support systems for persons with SMD.
MORTALITY AS AN OUTCOME MEASURE
The WHO estimate that 10–20 years of potential life is lost in SMD (1). This wide estimate is
derived from a number of meta-analyses containing data predominantly from HICs [e.g., (2)].
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Concerningly, there is new evidence from HICs that the gap is
increasing (3). What is the situation in LMICs? 10 years ago
there was debate as to whether some outcomes, at least for
schizophrenia, may in fact be better in developing countries (4,
5). This was based largely on three cross-national epidemiological
studies sponsored by the WHO [IPSS (6), DOSMeD (7), ISOS
(8)], which appeared to demonstrated higher rates of complete
remission and better social functioning and mortality rates
(expressed in standardized mortality ratios). However in a recent
high quality Ethiopian study, the average potential years of
life lost for persons with SMD was 28.4 years (9). This is
in keeping with other cohorts in Madras (10) and Bali (11)
which suggest mortality rates in LMICs may be in fact be
worse.
CAUSES OF DEATH IN SEVERE MENTAL
DISORDER
Our understanding of the causes of premature death in SMD
has undergone radical change in recent decades. Historical data
focusing on inpatient populations tended to over-estimate the
rate of unnatural deaths in SMD (suicide, but also accidents
and homicides). We now know that the mortality gap cannot
be attributed to this alone. A retrospective study in Australia
which linked data from mental and physical health services
reported that the excess deaths were attributable to physical
illnesses in over three-quarters of cases (3). This is in keeping
with data from other HICs, where meta-analyses have identified
cardiovascular diseases as the major cause of death in persons
with SMD (12). The limited data from LMICs also suggest
that the majority of deaths are due to natural illness (9–
11). However, reflecting the pattern in the general population,
infectious disease was the primary cause of death in an Ethiopian
study (9).
Unnatural causes still account for about a quarter of deaths
in persons with both in HICs and LMIC. This includes suicide,
for which there is an increased risk amongst persons with SMD,
especially within the first few years after contact with a psychiatric
service (9, 13), but also accidental death (more common than
suicide) and homicide (14, 15).
RISK FACTORS FOR EXCESS MORTALITY
The WHO have published a multilevel model for risk of excess
mortality in persons with SMD (1). It considers individual factors
(which can be disorder- or behavior-specific), health systems
(such as financing) and social determinants of health (such as
culture and societal values), highlighting the complexity of this
problem.
Taking cardiovascular ill-health as an example, the
contributing factors in persons with SMD may include
disease-specific pathogenic mechanisms (see the emerging
stress and inflammation theories), the metabolic side effects of
antipsychotics [higher doses have been associated with higher
risk of coronary heart disease and stroke (16)], behavioral factors
[persons with SMD, when compared to general population
controls, were less likely to be non-smokers or exercise to daily
recommendations, and had poorer health outcomes (17)] and
health system factors [persons with SMD are less likely to be
referred for coronary revascularization procedures after a heart
attack (18)] which are entwined with societal values.
Researchers in LMICs have called for further studies of the
mechanisms underlying death from natural causes in persons
with SMD (9). No doubt there will be identifiable risks at every
level of the WHOmodel.
THE ROLE OF PSYCHOSOCIAL
INTERVENTIONS IN REDUCING EXCESS
MORTALITY
To reduce the mortality gap in persons with SMD, interventions
are required at the individual to societal level. A full review of all
of the current evidence is beyond the scope of this mini-review.
We will focus on the psychosocial interventions aiming to tackle
individual, behavior-specific risk factors.
Persons with SMD want to quit smoking (19), and
there is some evidence of a modest benefit of smoking
cessation counseling delivered by psychiatrists: number of
cigarettes smoked in a typical week was significantly reduced
after 12 months, however rates of abstinence determined
by expired carbon monoxide was unchanged (20). There is
better evidence for weight-loss programmes. Persons with
SMD randomized to a tailored group weight management
education and exercise sessions have achieved significant weight
loss (21, 22) as well as reduced fasting glucose and medical
hospitalizations after 6 months (22). Interventions aiming to
reduce substance misuse and risky sexual behavior have had
mixed results. One study demonstrated that an enhanced
service delivered at the site of mental health treatment
significantly improved testing and immunization for blood-
borne infection, but despite risk reduction counseling (the
psychosocial element) led to no change in risk behavior
(23).
The evidence base for lifestyle psychosocial interventions in
persons with SMD is mixed in both quality and results. We
did not identify any studies in LMICs, where it is likely that
interventions to reduce risk behavior for blood-borne infections
would be highly relevant.
MODELS OF SUPPORT
In parallel with studies addressing specific risk behaviors,
different models for supporting persons with SMD to achieve
good physical health are being tested. There is evidence
that nurse led services, both as care managers (prompting
general and specialist services) and as practioners, can increase
screening rates for cardiovascular risk factors (24, 25). Further
studies will be required to determine if such enhanced
services for persons with SMD result in reduced mortality.
Another area of promise is peer-led intervention. In the
United States, a chronic disease self-management program,
adapted for persons with SMD and delivered by peers led
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to improvements in self-rated physical and mental health
scores (24). Importantly there was a clinically significant
improvement in “patient activation” a measure of “individual’s
perceived ability to manage his or her illness and health
behaviors.”
CONCLUSIONS
In conclusion, persons with SMD are dying younger than the
general population globally. There is an emerging consensus
that the majority of excess mortality is due to poor physical
health, with cardiovascular disease the major cause of
death in HICs. Risk factor levels range from the individual
(disorder and behavior specific) to the health system and
social determinants. Studies have demonstrated that lifestyle
psychosocial interventions have the potential to benefit persons
with SMD, through tobacco-smoking cessation, increased
activity and weight loss. Persons with SMD may require extra
support to achieve healthy lifestyles, and both nurse-led and
peer-led interventions have shown promise. However, the
current evidence base for lifestyle psychosocial interventions
is limited to HICs. With recent evidence demonstrating that
the mortality gap may be even higher for persons with SMD in
LMICs, this must become a focus for global health research.
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